576 related articles for article (PubMed ID: 15644086)
21. Quantitation and characterization of glutathionyl haemoglobin as an oxidative stress marker in chronic renal failure by mass spectrometry.
Mandal AK; Woodi M; Sood V; Krishnaswamy PR; Rao A; Ballal S; Balaram P
Clin Biochem; 2007 Sep; 40(13-14):986-94. PubMed ID: 17574228
[TBL] [Abstract][Full Text] [Related]
22. Melatonin prevents lipid peroxidation in human erythrocytes but augments deterioration of deformability after in vitro oxidative stress.
Dikmenoglu N; Ileri E; Seringec N; Ercil D
Clin Hemorheol Microcirc; 2008; 40(3):235-42. PubMed ID: 19029647
[TBL] [Abstract][Full Text] [Related]
23. Does treatment of renal anemia with recombinant erythropoietin influence oxidative stress in hemodialysis patients?
Sommerburg O; Grune T; Hampl H; Riedel E; Ehrich JH; Siems WG
Clin Nephrol; 2000 Feb; 53(1 Suppl):S23-9. PubMed ID: 10746802
[TBL] [Abstract][Full Text] [Related]
24. Lipid peroxidation and antioxidant enzymes in children on maintenance dialysis.
Zwołińska D; Grzeszczak W; Szczepańska M; Kiliś-Pstrusińska K; Szprynger K
Pediatr Nephrol; 2006 May; 21(5):705-10. PubMed ID: 16518626
[TBL] [Abstract][Full Text] [Related]
25. Antioxidant enzymes show adaptation to oxidative stress in athletes and increased stress in hemodialysis patients.
Knap B; Prezelj M; Buturović-Ponikvar J; Ponikvar R; Bren AF
Ther Apher Dial; 2009 Aug; 13(4):300-5. PubMed ID: 19695063
[TBL] [Abstract][Full Text] [Related]
26. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis.
Lucchi L; Iannone A; Bergamini S; Stipo L; Perrone S; Uggeri S; Gatti V; Ferrari F; Tomasi A; Albertazzi A
Artif Organs; 2005 Oct; 29(10):832-7. PubMed ID: 16185346
[TBL] [Abstract][Full Text] [Related]
27. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane.
Westhuyzen J; Saltissi D; Stanbury V
Ann Clin Lab Sci; 2003; 33(1):3-10. PubMed ID: 12661892
[TBL] [Abstract][Full Text] [Related]
29. Endothelial dysfunction and oxidative stress in chronic renal failure.
Ghiadoni L; Cupisti A; Huang Y; Mattei P; Cardinal H; Favilla S; Rindi P; Barsotti G; Taddei S; Salvetti A
J Nephrol; 2004; 17(4):512-9. PubMed ID: 15372412
[TBL] [Abstract][Full Text] [Related]
30. The importance of oxidative stress in patients with chronic renal failure whose hypertension is treated with peritoneal dialysis.
Demirci S; Sekeroğlu MR; Noyan T; Köçeroğlu R; Soyoral YU; Dülger H; Erkoç R
Cell Biochem Funct; 2011 Apr; 29(3):249-54. PubMed ID: 21465497
[TBL] [Abstract][Full Text] [Related]
31. [Oxidative stress as a reason of treatment difficulties in chronic renal failure].
Stepniewska J; Ciechanowski K
Pol Merkur Lekarski; 2005 Nov; 19(113):697-700. PubMed ID: 16498815
[TBL] [Abstract][Full Text] [Related]
32. Erythrocyte transmembrane electron transfer in haemodialysis patients.
Matteucci E; Cupisti A; Caprioli R; Battipaglia E; Favilla S; Rindi P; Barsotti G; Giampietro O
Nutr Metab Cardiovasc Dis; 2007 May; 17(4):288-93. PubMed ID: 17434051
[TBL] [Abstract][Full Text] [Related]
33. Protein thiol oxidation and lipid peroxidation in patients with uraemia.
Prakash M; Upadhya S; Prabhu R
Scand J Clin Lab Invest; 2004; 64(6):599-604. PubMed ID: 15370466
[TBL] [Abstract][Full Text] [Related]
34. Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients.
Ozden M; Maral H; Akaydin D; Cetinalp P; Kalender B
Clin Biochem; 2002 Jun; 35(4):269-73. PubMed ID: 12135687
[TBL] [Abstract][Full Text] [Related]
35. Red blood cell calcium homeostasis in patients with end-stage renal disease.
Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
[TBL] [Abstract][Full Text] [Related]
36. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
[TBL] [Abstract][Full Text] [Related]
37. Alterations of erythrocyte structure and cellular susceptibility in patients with chronic renal failure: effect of haemodialysis and oxidative stress.
Brzeszczynska J; Luciak M; Gwozdzinski K
Free Radic Res; 2008 Jan; 42(1):40-8. PubMed ID: 18324522
[TBL] [Abstract][Full Text] [Related]
38. The effects of trimetazidine on lipid peroxidation in patients with end-stage renal disease.
Aygen B; Celiker H; Dogukan A; Ilhan N
Methods Find Exp Clin Pharmacol; 2008 Dec; 30(10):757-60. PubMed ID: 19271025
[TBL] [Abstract][Full Text] [Related]
39. The effect of serum albumin level on iron-induced oxidative stress in chronic renal failure patients.
Sezer MT; Akin H; Demir M; Erturk J; Aydin ZD; Savik E; Tunc N
J Nephrol; 2007; 20(2):196-203. PubMed ID: 17514624
[TBL] [Abstract][Full Text] [Related]
40. Antioxidant therapy by oral vitamin E and vitamin E-coated dialyzer in CAPD and haemodialysis patients.
Mydlík M; Derzsiová K; Rácz O; Sipulová A; Lovásová E
Prague Med Rep; 2006; 107(3):354-64. PubMed ID: 17385408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
